Meningitis
Meningitis: Excerpt from Pediatric Infectious Disease
Bacterial Meningitis
Epidemiology
Bacterial meningitis is the most feared form of pediatric meningitis. Bacteria,
which colonize the skin, nasopharynx, or both, enter the bloodstream. These
bacteria then
“seed” the CSF. It is for this reason that blood cultures are positive in up to 90% of
children with bacterial meningitis.
Presentation
Patients with bacterial meningitis typically present with high fevers, headache,
and an altered mental state. The classic clinical triad of bacterial meningitis
is fever, nuchal rigidity, and a change in mental status, although only two
thirds of patients with bacterial meningitis actually have all three of these
symptoms. Kernig
’s sign is a clinical examination technique whereby 90% flexion of the hips
causes subsequent painful extension of the legs. Brudzinski
’s sign is involuntary flexion of the knees and hips after passive flexion of the
neck while supine. Although these clinical signs have traditionally been used
to evaluate for bacterial meningitis, recent studies in adults have found that
Kernig
’s and Brudzinski’s signs actually have a low sensitivity for predicting the presence of bacterial
meningitis. The entire clinical picture should be used in determining whether
to obtain a lumbar puncture.
Diagnosis
The major reported risk in obtaining a sample of CSF is that a preexisting
intracranial mass will cause a brainstem herniation following lumbar puncture.
There are also concerns that lumbar puncture could cause herniation in a child
who has increased intracranial pressure secondary to severe meningitis. Many
clinicians obtain a computed tomography (CT) scan of the head before obtaining
a lumbar puncture, although this may delay diagnosis and optimal therapy.
Although herniation remains a possibility in the setting of bacterial
meningitis, it remains an uncommon occurrence, with most estimates reporting an
incidence of
less than 5%. Although an increase in intracranial pressure is thought to be
present in virtually all cases of pediatric bacterial meningitis, it is also
known that CT of the brain is normal in most cases of bacterial meningitis,
including cases that had subsequent herniation following lumbar puncture. Most
specialists stress the need for an accurate history and physical examination
when deciding whether to obtain imaging before lumbar puncture. It is noted
that a patient with a mass lesion such as an abscess or brain tumor will
usually report symptoms over the preceding weeks, whereas in bacterial
meningitis, there is a history ranging from hours to days. The diagnosis of
impending cerebral herniation can often be made clinically from abnormalities
of the neurological exam, including sixth nerve palsy, dilated or fixed pupils,
and decerebrate posturing. In patients who have the clinical features of
impending herniation, lumbar puncture should be deferred and diagnostic testing
limited to blood cultures. Aggressive measures to reduce intracranial pressure
are mandatory in such a patient.
Cerebrospinal Fluid Examination
Examination of the CSF is critical. Typically, bacterial meningitis presents
with a CSF white blood cell count of several thousand white cells, most being
segmented neutrophils. The mean CSF white cell count in bacterial meningitis,
regardless of whether patients have been pretreated, is greater than 4,000/m
3. In bacterial meningitis, the protein concentration of the CSF will be high and
glucose concentration low. The probability of a positive Gram stain is
dependent on the number of bacteria present in the CSF, which may be related to
the timing of lumbar puncture in relation to the onset of symptoms. A positive
Gram stain of the CSF in bacterial meningitis is also related to the organism
causing the meningitis.
Streptococcus pneumoniae has the highest rate of having a positive Gram stain (about 90%), with Neisseria meningitidis having a positive Gram stain in about 75% of cases. CSF cultures are more likely
to be positive in patients who had lumbar puncture before the administration of
antibiotics.
Management
Empiric Therapy for Bacterial Meningitis
When faced with a patient with presumed bacterial meningitis, it is optimal to
start appropriate antibiotics as early as possible. The
“Gram stain game” can help in this decision. The following are the major pathogens of pediatric
bacterial meningitis.
1. Streptococcus agalactiae: group B streptococcus. A gram-positive coccus, group B streptococcus is a common cause of neonatal
meningitis. Up to one half of women are colonized with
S. agalactiae in the genital tract; neonates become colonized at the time of delivery. A
certain percentage of these neonates then become bacteremic, which can result
in CSF infection. Therapy is with ampicillin and gentamicin.
2. Streptococcus pneumoniae. Another gram-positive coccus, this is the most common cause of infant and
toddler meningitis. The mechanism is similar to that of group B streptococcus,
whereby colonizing bacteria entering the bloodstream with subsequent infection
of the CSF.
3. Neisseria meningitidis. A gram-negative diplococcus, this can cause rapid onset of meningitis, septic
shock, and death. Septic shock associated with
N. meningitidis is often associated with rapid onset of petechial and purpuric lesions. Therapy
is with a third-generation cephalosporin or intravenous penicillin.
4. Listeria monocytogenes. A gram-positive rod, this organism is ubiquitous in the environment and
commonly found in unpasteurized food products. Meningitis usually occurs in the
neonatal period and in immunocompromised patients. This is the one cause of
bacterial meningitis not sensitive to the third-generation cephalosporins.
Ampicillin is the drug of choice, used in combination with gentamycin. For
patients who cannot tolerate ampicillin, intravenous
trimethoprim-sulfamethoxazole is recommended as the second choice. Vancomycin
may be a
successful alternative antibiotic, although treatment failures have also been
reported.
5. Haemophilus influenzae (type b). Before the development of the conjugate vaccine, this gram-negative
coccobacillus frequently caused invasive disease. Pediatricians rarely
encounter type b
H. influenzae meningitis in unvaccinated populations. There are increasing reports of
nontypeable
Haemophilus causing invasive disease, including meningitis. Treatment is with a
third-generation cephalosporin; ampicillin can be used if the causative
bacteria are
β-lactamase negative.
Special Considerations: Treatment of Streptococcus pneumoniae
The most common cause of infant and toddler meningitis remains S. pneumoniae, although this may ultimately change owing to the recent addition of the
conjugate vaccine to primary immunization series.
Resistance of S. pneumoniae. One of the major issues in the treatment of pneumococcal meningitis is the
increasing resistance to penicillin and cephalosporins. Resistance is mediated
by alterations in penicillin-binding proteins. This increases the minimal
inhibitory concentration (MIC) to both these antibiotics; that is, increased
concentrations of antibiotic are needed to inhibit growth of bacteria. The
problem faced with treating meningitis in the context of increasing MIC is as
follows:
The breakpoint is the highest MIC at which an organism is defined as sensitive to a given
drug. The desire to achieve a CSF concentration of 10 times the MIC explains
the breakpoints for penicillin and third-generation cephalosporins for the
treatment of
S. pneumoniae meningitis. The maximal concentration of penicillin obtained in the CSF is about
1.0
µg/mL. The breakpoint for the use of penicillin in pneumococcal meningitis is
0.06
µg/mL; any MIC to penicillin of an infecting pneumococcus greater than this does
not guarantee a concentration 10 times the MIC. The maximal concentration for a
third-generation cephalosporin in the CSF is about 5.0
µg/mL. The breakpoint for cefotaxime or ceftriaxone is 0.5 µg/mL; if the MIC is greater than 0.5, a concentration in the spinal fluid of 10
times the MIC cannot be ensured.
Rates of resistance vary from community to community. Rates of S. pneumoniae with an MIC to penicillin greater than 0.1 µg/mL can be as high as 75%. Rates of pneumococcus with an MIC to a
third-generation cephalosporin greater than 0.5
µg/mL can approach 20%. These numbers may increase as antibiotic overuse
persists. It is for this reason that empiric therapy for presumed pneumococcal
meningitis includes vancomycin (15 mg/kg given intravenously every 6 hours) and
a third-generation cephalosporin. All pneumococcal isolates from the CSF should
be tested for MIC to penicillin and third-generation cephalosporins. After
specific MICs are available, therapy can be tailored appropriately.
There is little experience, although justifiable concern, in the management of
children with pneumococcal meningitis in which the isolated bacteria has an MIC
to cefotaxime or ceftriaxone greater than 2.0
µg/mL. In those cases, treatment with both vancomycin and a third-generation
cephalosporin is recommended. The addition of rifampin, 20 mg/kg in two divided
doses, should also be considered.
Meropenem is a new antibiotic that has excellent gram-negative coverage and good
CSF penetration. Although approved for children 3 months of age or older with
penicillin-susceptible pneumococcal meningitis, there is little clinical
experience with this drug in resistant pneumococcal isolates. In the coming
years, more data regarding meropenem in the treatment of resistant pneumococcal
meningitis will be available.
Steroid Therapy for Bacterial Meningitis
During the past decade, increasing attention has been given to adjunctive
treatment for bacterial meningitis. It is recognized that bacterial meningitis
is a disorder of intense inflammation and that this inflammation can result in
substantial morbidity, primarily in the form of hearing loss. For patients with
H. influenzae type B meningitis, dexamethasone is recommended. The dose is 0.15 mg/kg of
dexamethasone every 6 hours for 4 days.
The use of steroids in pneumococcal meningitis is more controversial. A major
concern is a possible decrease in antibiotic concentration in the CSF when
steroids are given. In animal models, vancomycin concentration was altered up
to 75% when concurrent steroids were used. The few clinical trials performed
have not shown CSF differences in vancomycin and cefotaxime concentrations in
the presence of dexamethasone. Two retrospective studies regarding outcome in
patients with resistant pneumococcal meningitis receiving dexamethasone have
been published, reaching different conclusions. In a small number of children
with bacterial meningitis who received both vancomycin and dexamethasone,
vancomycin levels in the CSF were comparable to those measured in children who
receive vancomycin without dexamethasone. At this point, the opinion of the
American Academy of Pediatrics is that the clinician needs to evaluate each
case individually, weighing risks and benefits of steroid use.
Aseptic Meningitis
Etiology
The term aseptic meningitis is defined as meningitis associated with negative bacterial cultures. Most cases
of aseptic meningitis are caused by viral pathogens, with enterovirus being the
leading cause. Enteroviruses comprise several serotypes, including
coxsackievirus, echovirus, and poliovirus. These pathogens predominate in the
summer or fall months and may cause epidemics of disease.
Presentation
Patients usually present with acute onset of fever, headache, and vomiting.
Clinical signs of meningeal irritation may be present. Photophobia and myalgias
are common. There may be an associated gastroenteritis. Patients are typically
not as acutely ill as those with bacterial meningitis.
Evaluation of Cerebrospinal Fluid
A common challenge facing the pediatrician is using the results of the CSF to
determine whether the child has aseptic meningitis. Aseptic meningitis is
typically characterized by a few hundred white blood cells, most of which are
lymphocytes. In contrast, bacterial meningitis is characterized by thousands of
white blood cells with a segmented neutrophil predominance. It also should be
noted that in most cases of bacterial meningitis, there are other abnormalities
seen in the CSF, such as a positive Gram stain and low glucose and high protein
levels.
Standard textbooks also state that aseptic meningitis can have a predominance of
polymorphonuclear cells early in the course of disease. It has long been
thought that in aseptic meningitis with an early segmented neutrophil
predominance, repeat lumbar puncture after 24 hours will document the typical
picture of lymphocytic predominance. Recent studies have challenged this
assumption; one study showed that most children with aseptic meningitis in the
height of the enteroviral season actually maintained a predominance of
segmented neutrophils in the CSF even after the first 24 hours of illness.
These same studies also pointed out that the average number of white blood
cells in patients with viral meningitis remains in the low 100s, whereas in
bacterial meningitis, it is several thousand. Ultimately, the clinician
evaluating the CSF from a patient will need to consider the entire clinical
picture, including history, clinical exam, and abnormalities of the spinal
fluid.
Diagnosis
Enterovirus can be cultured from CSF. Polymerase chain reaction (PCR) has been
shown to be more sensitive than culture, and in many settings, results can be
available in less than 24 hours.
Management
Treatment is generally supportive, including hydration and pain management.
Encephalitis
Etiology
Encephalitis can be caused by any of a long list of infectious agents. These
pathogens can cause encephalitis by either direct invasion of the brain or by a
postinflammatory effect. The exact mechanisms for certain agents are not well
defined.
Determining the etiology of a particular encephalitis can be challenging. Brain
biopsy is usually not performed. Many pathogens causing encephalitis are
fastidious and are difficult to grow in standard culture. Serology has
historically been a mainstay of diagnosis; recent advances in PCR technology
have been employed to maximize yield in the diagnosis of encephalitis.
Presentation
Patients with encephalitis usually are sicker than those with typical aseptic
meningitis because the brain itself is inflamed. Seizures are common, as are
focal neurologic deficits and cognitive disturbances. CSF often shows an
“aseptic” picture with several hundred white blood cells, most of which are lymphocytes.
The following is a brief discussion of the major pathogens implicated in
pediatric encephalitis. In evaluating a patient with encephalitis, a complete
history, particularly in regard to travel, animal exposure, concurrent
immunosuppression, and geographic location, is critical.
Herpes Simplex Virus
Epidemiology and Etiology
Herpes simplex virus (HSV) is responsible for up to 30% of diagnosed adult viral
encephalitis. Infection is thought to begin with colonization or infection in
the nasopharynx; invasive disease can then result because HSV has an affinity
for the frontal and temporal lobes of the brain.
Presentation
The clinical spectrum of herpes simplex encephalitis has been reevaluated as
diagnostic testing has become more sensitive. Once thought to be primarily a
cause of acute encephalitis, it is appreciated that a more chronic course,
including febrile seizures and progressive loss of higher cognitive function,
is possible. The focal hemorrhagic nature of herpes encephalitis is well
described. Younger patients are more likely to have characteristic lesions in
areas other than the temporal lobes typically described in adults. Seizures are
common, and progression to coma is frequently seen.
Diagnosis
The diagnosis of herpes simplex involves several techniques.
Electroencephalography is a noninvasive technique that shows temporal lobe
spikes in about 80% of cases. Viral culture of the CSF is not very sensitive,
resulting in positive cultures in only 20% of cases. PCR of the spinal fluid is
considered to be the new gold standard for diagnosis of herpes simplex
encephalitis. Although PCR of spinal fluid offers an improvement over previous
diagnostic techniques, caution should be employed. Recent studies have shown
that young children may have negative PCR in CSF, especially if CSF is sampled
on the first or second day of illness. It has been postulated that early in HSV
encephalitis, the virus is in the brain but is absent from the CSF. Evaluation
for herpes simplex encephalitis in young children should take into account the
entire clinical picture, particularly if characteristic lesions are seen on
neuroimaging. In certain cases in which the clinical picture is consistent with
herpes simplex encephalitis, a second CSF sample should be obtained. Antiviral
therapy will have little effect on the presence of HSV DNA in the CSF; prior
administration of acyclovir should not preclude the continuing evaluation for
herpes simplex in the CSF.
Management
Enteroviruses
Epidemiology and Etiology
Enteroviruses are in the family Picornaviridae, which includes poliovirus,
coxsackie, and echovirus. These are a major cause of both pediatric aseptic
meningitis and encephalitis. Epidemics of nonpolio enteroviral infections
frequently occur in late summer and early fall.
Presentation
Children with enteroviral encephalitis initially may have fever, headache, and
photophobia, often accompanied by symptoms of gastroenteritis. Encephalitis
will then manifest with seizures, focal neurologic deficits, and altered mental
status. Neonates with enteroviral disease may have a disseminated illness that
closely resembles that caused by herpes simplex virus. These neonates in the
first weeks of life may present with fever, liver failure, and coagulopathy.
Diagnosis
Diagnosis of enteroviral disease is as described previously. PCR can be obtained
on serum and CSF and is the quickest and most sensitive diagnostic test.
Management
Treatment is generally supportive. Pleconaril is an oral antiviral agent that
has been shown in compassionate use trials to be effective in some cases of
severe disease, including disseminated neonatal disease.
Mycoplasma pneumoniae
Epidemiology and Etiology
M. pneumoniae is a common respiratory pathogen that is thought to be a major cause of
pediatric encephalitis. In some series, it is the leading identifiable cause of
encephalitis in children.
The organism has been isolated from brain and CSF by culture and PCR. Isolation
implies direct invasion of the pathogen, although
M. pneumoniae has also been implicated as a cause of immune-mediated disease, such as acute
demyelinating encephalopathy, Guillain-Barr
é syndrome, and transverse myelitis. The mechanism of immune-mediated disease is
proposed antigenic similarities between
M. pneumoniae and human neural tissue. It is speculated that patients with shorter prodromes
may have a direct-invasion disease mechanism, whereas those with longer
prodromes may have immune-mediated disease.
Presentation
Prodromal respiratory illness lasting days to weeks occurs in some patients,
although disease has been documented without preceding respiratory symptoms.
Mycoplasma encephalitis can be associated with focal neurologic signs thought
to be the result of associated acute demyelination.
Diagnosis
The diagnosis of M. pneumoniae encephalitis is by culture, PCR of the CSF, or both. Serology can also be used,
although false-negative results can occur.
Management
Treatment is supportive. A variety of treatments, including antibiotics
intravenous
immune globulin and corticosteroids, have been attempted, although there is no
definite consensus as to their use.
Pediatric Viral Infections
A large number of common pediatric viral infections have been reportedly
associated with encephalitis. These include Epstein-Barr virus, influenza
virus, and cytomegalovirus. The mechanism of the encephalitis is not known,
being either direct viral invasion or secondary immune response. In the setting
of encephalitis, serologies for these pathogens, as well as PCR studies, can be
useful in diagnoses.
Arboviruses
Arboviruses are arthropod-borne viruses spread by mosquitos, ticks, or sand
flies. These pathogens cause a wide spectrum of illness ranging from
self-limited febrile illnesses to aseptic meningitis to encephalitis. Certain
arboviruses are present in specific regions in the United States and usually
occur in late summer and early autumn.
California encephalitis (La Crosse Virus)
Etiology
La Crosse encephalitis is caused by Bunyavirus. The name is a misnomer,
reflecting not geographic location but rather the initial place of discovery.
The disease is actually found in the Midwestern and Eastern United States. It
is often considered the most common pediatric arboviral infection in the United
States.
Presentation
There is a spectrum of disease from mild febrile illness to aseptic meningitis
to fatal encephalitis. There is usually a febrile prodrome, which can include
headache and vomiting. La Crosse encephalitis occurs mostly in children;
seizures are the presenting symptom in one half of cases. Focal neurologic
signs, including paralysis, are seen in one fourth of cases.
Diagnosis
Diagnosis is by serologic methods, usually an immunoglobulin M (IgM)
enzyme-linked immunosorbent assay (ELISA) capture antibody.
Management
Treatment is supportive. Ribavirin has been used in clinical trials, although no
definitive proof of its usefulness exists.
St. Louis Encephalitis
Etiology
St. Louis encephalitis is caused by a virus in the Flaviviridae family. This is
considered an important arboviral infection due to its ability to cause
epidemics of disease. A large number of cases have been reported in midwestern
states as well as in Texas, Louisiana, and Florida.
Presentation
Patients with St. Louis encephalitis often present with headache and fever.
Associated paralysis or weakness can occur, as can multiple cranial nerve
palsies.
Diagnosis
Diagnosis is by serology, usually IgM ELISA.
Management
Treatment is supportive. No specific medical therapy is currently available.
West Nile Virus
Etiology
West Nile virus is the arbovirus most reported in the medical news. It appeared
in North America in 1999 in New York City, causing 62 cases, with seven deaths.
A flavivirus found commonly along major bird migration pathways, it is
transmitted to birds by mosquitos, which can also infect humans. Transmission
through organ transplantation, blood transfusion, and breast milk has also been
reported.
Presentation
Most infections are asymptomatic; infection can also be a self-limited febrile
illness sometimes accompanied by a transient rash. Less than 1% of infections
result in encephalitis. Extremes of age appear to be a risk factor for
encephalitis. Patients with central nervous system involvement can exhibit
encephalitis, abnormalities of movement, and ocular motor dysfunction.
Examination of the CSF shows pleocytosis, with the majority of cells being
mononuclear. Early signs of more severe neurologic disease include
Guillain-Barr
é syndrome and transverse myelitis and can provide a clue to diagnosis.
Diagnosis
Diagnosis of West Nile virus is made primarily by serology. ELISA or
immunofluorescent assay (IFA) are frequently used. PCR assays are also becoming
available. Viremia, as detected by PCR, can be found before the onset of
symptoms.
Management
There is no specific therapy for West Nile virus encephalitis. Ribavirin has
been shown to inhibit the virus in neural cell cultures and has been
administered to a small number of patients. There is no consensus on treatment.
The major role of medical treatment remains supportive care (Table 11.1).
Fungal Meningitis
Fungal meningitis is usually, but not exclusively, seen in patients with
underlying immunodeficiency. The major organisms to be considered include
Coccidioides immitis and Cryptococcus neoformans.
Coccidioides immitis Infection
Etiology
This dysmorphic fungus is found in soil and infects people through inhalation of
airborne spores.
Presentation
The most common manifestation in the normal host is a self-limited bronchitis.
Disseminated disease occurs in less than 1% of infections, with the bones,
skin, and central nervous system being common secondary sites. Severe disease
is frequent in patients with underlying T-cell immunodeficiency, such as those
infected with the human immunodeficiency virus (HIV). It can also be found in
normal hosts, with African-American and Filipino patients at higher risk for
disseminated disease.
In the immunocompetent host, the cerebrospinal profile is similar to a viral
meningitis with several hundred cells, most of which are lymphocytes. In the
severely immunocompromised patient, there may not be adequate functioning
lymphocytes to cause an appropriate inflammatory response. In these patients,
there may be a normal CSF even in the face of a severe fungal meningitis.
Diagnosis
Complement fixation antibodies in the serum and CSF are often used to make the
diagnosis. Increasing antibody titers indicate progressive disease. Fungal
cultures of CSF can also be used for the diagnosis.
Management
Treatment is always indicated for coccidioidomycosis meningitis. Treatment of
coccidioidomycosis meningitis is usually with oral fluconazole, which achieves
good levels in the CSF. Dosage is 400 mg per day, although doses as high as 1 g
per day have been used. As with any granulomatous meningitis, hydrocephalus
secondary to obstruction of cerebrospinal flow is always a possibility. If this
complication develops, a ventriculoperitoneal shunt may be required. Therapy is
typically indefinite in patients with CNS infection because withdrawing of
medication often results in relapsed infection.
Cryptococcus neoformans Infection
Etiology
The etiology ofC. neoformans meningitis is similar to that of coccidioidomycosis; it is found in soil
contaminated with bird droppings and causes infection through inhalation of the
organism.
Presentation
In patients with HIV infection, it is one of the most common causes of central
nervous system infection. These patients present with a severe headache but can
also present with behavioral changes or focal neurologic signs.
Diagnosis
In patients with underlying immunodeficiency, the CSF may not contain numerous
lymphocytes. Encapsulated yeast can be visualized by India ink staining of the
spinal fluid. Antigen detection against the capsular polysaccharide of the
organism in CSF is positive in more than 90% of patients. The organism can also
be grown in fungal culture.
Management
Treatment of cryptococcal meningitis is with amphotericin B in doses of 0.5 to
0.7 mg/kg per day in combination with oral flucytosine (5-FC). When flucytosine
is used, serum concentration should be monitored, as should complete blood
counts. Patients should continue combination therapy for at least 2 weeks or
until repeat culture of the CSF is negative. Immunocompromised patients with
cryptococcal meningitis, as in patients with
C. immitis meningitis, typically receive lifelong maintenance therapy with fluconazole.
Selected Readings
De Tiège X, Heron B, Lebon P, et al. Limits of early diagnosis of herpes simplex
encephalitis in children: a retrospective study of 38 Cases.
Clin Infect Dis 2003;36(10):1335–1339.
Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies:
diagnostic challenges in the California Encephalitis Project 1998
–2000. Clin Infect Dis 2003;36(6):731–742.
Greenlee JE. Approach to diagnosis of meningitis. Cerebrospinal fluid
evaluation.
Infect Dis Clin North Am 1990;4(4):583–598.
Oliver WJ, Shope TC, Kuhns LR. Fatal lumbar puncture: fact verus fiction. An
approach to a clinical dilemma.
Pediatrics 2003;112(3):3 174–176.
Pictures
Book Source Details
- Book Title: Pediatric Infectious Disease
- Author(s): Donald Janner MD
- Year of Publication: 2004
- Copyright Details: Pediatric Infectious Disease, Copyright © 2004 Lippincott Williams & Wilkins.
More About Cryptococcal Meningitis
More Medical Textbooks Online about Cryptococcal Meningitis
Review other book chapters online related to Cryptococcal Meningitis:
Medical Books Excerpts
- HEADACHE
- "Algorithmic Diagnosis of Symptoms and Signs" (2003)
- [ read ]
- Headache
- "In A Page: Pediatric Signs and Symptoms" (2007)
- [ read ]
- HEADACHE
- "Differential Diagnosis in Primary Care" (2007)
- [ read ]
- Headache
- "Handbook of Signs & Symptoms (Third Edition)" (2006)
- [ read ]
- Headache
- "A Pocket Manual of Differential Diagnosis" (1999)
- [ read ]
- Headache
- "Professional Guide to Diseases (Eighth Edition)" (2005)
- [ read ]
- Meningitis
- "Professional Guide to Diseases (Eighth Edition)" (2005)
- [ read ]
- Headache
- "Professional Guide to Signs & Symptoms (Fifth Edition)" (2006)
- [ read ]
- Photophobia
- "Professional Guide to Signs & Symptoms (Fifth Edition)" (2006)
- [ read ]
- Headache
- "The 10-Minute Diagnosis Manual: Symptoms and Signs in the Time-Limited Encounter" (2000)
- [ read ]
- Kernig's sign
- "Alarming Signs and Symptoms: Lippincott Manual of Nursing Practice Series" (2007)
- [ read ]
- Headache
- "Signs & Symptoms: A 2-in-1 Reference for Nurses" (2007)
- [ read ]
- Photophobia
- "Signs & Symptoms: A 2-in-1 Reference for Nurses" (2007)
- [ read ]
- Headache
- "The Diagnostic Approach to Symptoms and Signs in Pediatrics" (2006)
- [ read ]
- Headache
- "Nursing: Interpreting Signs and Symptoms" (2007)
- [ read ]
Copyright notice for book excerpts: Copyright © 2008 Lippincott Williams & Wilkins. All rights reserved.
|
|
More About This Book:
Title: Pediatric Infectious Disease
Authors: Donald Janner MD
Publisher: Lippincott Williams & Wilkins
Copyright: 2004
ISBN: 0-7817-5584-0
|
|
» Next page: Surveys relating to Cryptococcal Meningitis
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards: